Rutgers Cancer Institute of New Jersey

OrganisationROR

Trials

NCT02621398
Collaborator, Phase 1, Completed, 23 people, 3 Dec 2015
NCT02420652
Collaborator, Phase 2, Terminated, 27 people, 20 Apr 2015
NCT02315196
Collaborator, Phase 2, Active, not recruiting, 62 people, 11 Dec 2014
NCT01745588
Collaborator, Phase 2, Completed, 23 people, 10 Dec 2012
NCT01510119
Collaborator, Phase 1/2, Completed, 40 people, 13 Jan 2012
NCT01407562
Collaborator, Phase 1, Terminated, 34 people, 2 Aug 2011
NCT01220973
Collaborator, Phase 2, Completed, 27 people, 14 Oct 2010
NCT01009931
Collaborator, Phase 2, Terminated, 1 person, 9 Nov 2009
NCT00905918
Collaborator, Phase 1, Completed, 14 people, 21 May 2009
NCT00770666
Collaborator, Phase 4, Completed, 127 people, 10 Oct 2008
NCT00634634
Collaborator, Phase 1/2, Completed, 52 people, 13 Mar 2008
NCT00608972
Collaborator, Phase 2, Completed, 31 people, 6 Feb 2008
NCT00295932
Collaborator, Phase 1/2, Completed, 79 people, 24 Feb 2006
NCT00118066
Collaborator, Phase 2, Terminated, 12 people, 11 Jul 2005

Hepatocyte mitochondrial NAD+ content is limiting for liver regeneration
Consulting or advice, Shares or equity, Patents or royalties, Founder, Board or leadership role, 20 Nov 2025
Angiogenesis-independent VEGF signaling enhances exercise capacity by increasing fat oxidation in mice fed sulfur amino acid-restricted diets
Consulting or advice, Shares or equity, Patents or royalties, Founder, Board or leadership role, 20 Nov 2025
Aged mice exhibit widespread metabolic changes but preserved major fluxes
Consulting or advice, Shares or equity, Patents or royalties, Founder, Board or leadership role, 16 Oct 2025
Reprogramming neuroblastoma by diet-enhanced polyamine depletion
Shares or equity, Founder, Board or leadership role, 24 Sept 2025
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels
Consulting or advice, Shares or equity, Founder, Board or leadership role, 16 Nov 2020